Anpac Bio proud to sponsor the inaugural ‘Anpac Bio World Youth Innovation Forum’, at 2016 World Nobel Prize Laureate Summit, featuring the theme”Serendipity in Science”

Seven Nobel Prize Laureates and over 20 internationally acclaimed researchers and scientists, are presenting at the third annual, World Nobel Prize Laureate Summit in Chengdu, China, September 2-3, 2016. The 2016 WNPLS’ will feature three programs of scientific exploration: 1) Anpac Bio World Youth Innovation Forum; 2) International Symposium for Precision Medicine; and 3) the Bio-Pharmaceutical Industry Forum.

 International life sciences leader Anpac Bio-Medical Science Company has developed breakthrough, proprietary, "Cancer Differentiation Analysis" technology that effectively reinvents cancer screening and early detection. Anpac's proprietary CDA medical devices analyze simple, standard, non-invasive "Blood Biopsies" - resulting in measurably greater early cancer detection sensitivity and specificity, with no harmful side effects in patients. ...

Corporate sponsor Anpac Bio-Medical Science Company will host WNPLS’ Program I: “Anpac Bio World Youth Innovation Forum” (ABWYIF). Featuring the theme, “Serendipity in Science”, the ABWYIF will differ from many scientific meetings by focusing on the importance of “chance” in the process of scientific research. Presenting Nobel Laureates will share with thousands of young scientists their own, personal experiences of scientific inquiry, challenges, failures, and disruptions, before eventually achieving their Nobel Prize Award-winning breakthroughs.

The ABWYIF participating Nobel Prize Laureates will present at:

  • Richard J. Roberts, WNPLS Co-Chair & 1993 Nobel Laureate, Physiology or Medicine:
    • 9/2/2016: 13:30 pm
    • 9/3/2016: 09:50 am
  • Daniel Kahneman, 2002 Nobel Laureate, Economic Sciences & 2016 WNPLS Speaker
    • 9/2/2016: 13:40 pm
  • Sheldon L. Glashow, 1979 Nobel Laureate, Physics & 2016 WNPLS Speaker
    • 9/2/2016: 13:45 pm
  • Martin L. Chalfie, 2008 Nobel Laureate, Chemistry & 2016 WNPLS Speaker
    • 9/2/2016: 14:30 pm
  • Craig C. Mello, 2006 Nobel Laureate, Physiology or Medicine & 2016 WNPLS Speaker
    • 9/2/2016: 15:15 pm
  • Harald zur Hausen, 2008 Nobel Laureate, Physiology or Medicine & 2016 WNPLS Speaker
    • 9/2/2016: 16:00 pm
  • Aaron Ciechanover, 2004 Nobel Laureate, Chemistry & 2016 WNPLS Speaker
    • 9/3/2016: 09:05 am

Six Nobel Prize Laureate's and over 20 internationally acclaimed researchers and scientists, will present at the third annual, "World Nobel Prize Laureate Summit" (WNPLS) in Chengdu, China, September 1-3, 2016. The 2016 WNPLS' will feature three programs of scientific exploration: 1) "Anpac Bio World Youth Innovation Forum"; 2) "International Symposium for Precision Medicine"; and 3) the "Bio-Pharmaceutical Industry Forum".

Anpac Bio will post highlights of the #WNPLS2016 and #ABWYIF on AnpacBio.com and the Anpac Bio LinkedIn pages throughout the event.

“Anpac Bio-Medical Science Company is very proud to sponsor the inaugural ‘Anpac Bio World Youth Innovation Forum’, at this year’s ‘World Nobel Prize Laureate Summit’,” states Chris Yu, Anpac Bio CEO and ABWYIF Moderator. “Our company’s mission is to foster novel and innovative technology to detect and treat disease. Many of our breakthroughs were the result of both persistence and ‘Serendipity in Science.’ We hope that the Laureates’ presentations will demonstrate through hard work, overcoming and investigating obstacles, and ‘following the science’, promising young scientists will be inspired to realize their own Nobel dreams!”

Led by Zhan Qimin, Director of China’s State Key Laboratory of Molecular Oncology, WNPLS’ Program II, the “International Symposium for Precision Medicine”, will highlight research advancements and breakthroughs in Precision Medicine – particularly impacting cancer research. Among the subjects presented in WNPLS Program II: Cellular and Molecular Biology, Chemistry in Cancer, Tumor Genesis, Clinical Research Trials, Epidemiology, Endocrinology, Targeted Molecular Therapy, and Immunology, among others.

WNPLS’ Program III is the “Bio-Pharmaceutical Industry Forum” – encouraging WNPLS participants to build new connections with Bio-Pharmaceutical contemporaries, while connecting in lively and thought-provoking discussions, and learning directly from world-renowned leaders engaging Bio-Pharmaceutical advancements in the ongoing battle against cancer.

The meeting of international researchers and scientists at the WNPLS is due to the cooperation of a multi-national coalition, including: International Society of Scientific Communications for Nobel Prize Laureates (ISSCNL); China Association of Chinese Medicine; Chinese Medical Doctor Association; China International Conference Center for Science and Technology; Technology World Nobel Medical Media Company; sponsors; Chengdu Provincial Government; the Chengdu Hi-Tech Industrial Development Zone; and others.

“The vision of the World Nobel Prize Laureate Summit is to bring the world’s most eminent scientists together in China, to organize and improve collaborative efforts with their counterparts, and to invigorate a new generation of young students and scientists,” states Roberts. “I hope that the participants attending this meeting will find the talks inspirational and thought-provoking; and will be stimulated to make groundbreaking discoveries that will revolutionize the biosciences and benefit mankind.”

Related Links

Anpac Bio CEO Keynote Speaker at UC Biomedical & Engineering Entrepreneurship Academy

SACRAMENTO, Calif., July 8, 2016  — Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, will deliver the Keynote Address to award-winning life and technical science students, faculty, administration, corporate partners, officials, and general public, to launch the University of California Biomedical & Engineering Entrepreneurship Academy (BMEA), Monday, July 11, 2016 at 6 pm.

Hosted by/at the University of California, Davis Institute for Innovation and Entrepreneurship (Institute) and co-sponsored by UCD’s Biomedical Engineering DepartmentSchool of MedicineSchool of Veterinary Medicine, Graduate School of Management and Office of Research, the BMEA is considered one of UC’s premiere programs for commercializing science and engineering innovations. BMEA attendees, recognized by their UC campus leadership statewide as aspiring and early-stage scientific innovators, are graduates/undergraduates, postdoctoral research fellows, and life sciences/biomedical engineering faculty, that receive deep immersion in business development and other skills necessary to move their research out of the lab and successfully into the marketplace.

Dr. Yu, an accomplished serial entrepreneur, innovative physicist, and pioneering inventor, will present, “Game Changing Innovation: An Unconventional Path to Success,” sharing with attendees how his own road to success was not always smooth. Several times, Dr. Yu had to challenge the conventional thought and leadership of the day, to achieve breakthrough science and technology advancement. His speech will also provide practical tips, tools, and advice for achieving career success through true innovation and disruption; offer suggestions on recruiting appropriate mentors to assist and champion efforts/ideas; and encourage attendees to challenge conventional thought/leadership if necessary, to achieve long-lasting and profound breakthroughs benefiting mankind.

The BMEEA launch event featuring Dr. Yu’s Keynote Address, is open and free to the public: https://www.eventbrite.com/e/entrepreneurship-academy-keynote-mixer-featuring-dr-chris-yu-anpac-bio-medical-tickets-25842764404.

Anpac Bio also underwrote five, “Anpac Bio-Medical Innovation & Entrepreneur Fellowships” to UC students statewide that demonstrate particular promise to participate in September’s University of California Entrepreneurship Academy (UCEA).

“We are very excited and proud to enter into this new partnership with Anpac Bio-Medical Science Company and host Dr. Yu as the Academy’s Keynote speaker,” states Cleveland Justis, Institute Executive Director. “The Anpac-sponsored fellowships will allow us the funding and flexibility to recruit and award life science’s brightest minds, most talented academics, and worthy participants displaying promise as entrepreneurs or ‘corporate intrepreneurs’, to attend our academies. Anpac’s sponsorship of the Biomedical and Engineering Entrepreneurship Academy will underwrite a terrific event and attract top-notch keynote speakers like Dr. Yu, to inspire our academy students.”

Related Links

 

Anpac Bio-Medical Science Pledges $50,000 to UC Davis ChildFamily Institute for innovation and Entrepreneurship

Anpac Fellowships Underwrite University of California Students to Attend Scientific Innovation Academies

SACRAMENTO, Calif., Jan. 7, 2016 — Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, has pledged $50,000 to the University of California, Davis Child Family Institute for Innovation and Entrepreneurship (UCDCFIIE) to underwrite student fellowships and support UC Davis’ annual Biomedical and Engineering Entrepreneurship Academy.

Anpac’s $10,000 per year/five-year commitment will underwrite two UCDCFIIE programs annually: fellowships at the UC Entrepreneurship Academy and sponsorship of UC Davis’ annual Biomedical and Engineering Entrepreneurship Academy launch event.

The annual “Anpac Bio-Medical Innovation & Entrepreneur Fellowships” will underwrite five UC students from throughout California to participate in UCDCFIIE’s successful UC Entrepreneurship Academy (UCEA). Considered one of UC’s premier programs for commercializing science and engineering innovations, the UCEA is a springboard for moving research out of the lab and into the world, providing deep immersion in business planning for aspiring and early-stage scientific innovators.

In addition to the fellowships, Anpac will underwrite UC Davis’ Biomedical and Engineering Entrepreneurship Academy (UCDBMEA) opening event.

The UCDBMEA is co-sponsored by the UC Davis Biomedical Engineering Department, School of Medicine, School of Veterinary Medicine, Office of Research and the Child Family Institute for Innovation and Entrepreneurship. The academy’s opening event attracts faculty, lab clinicians and postdoctoral students, as well as UC and other academic leaders, corporate and external partners, and elected officials, among others. Anpac Bio-Medical will underwrite and host this event and partner with UC Davis to recruit world-renowned scientists as keynote speakers.

“We are very excited and proud to enter into this new partnership with Anpac Bio-Medical Science Company,” states Cleveland Justis, UCDCFIIE executive director. “The Anpac-sponsored fellowships will allow us the funding and flexibility to recruit and award life science’s brightest minds, most talented academics, and worthy participants displaying promise as entrepreneurs or ‘corporate intrepreneurs,’ to attend our academies. Anpac’s sponsorship of the Biomedical and Engineering Entrepreneurship Academy will underwrite a terrific launch event and attract world-renowned keynote speakers to inspire our academy students. We are honored that Anpac values our institute’s mission and goals. And we look forward to a long and positive relationship with Anpac as we continue to grow our programs and encourage the next generation of scientific innovation.”

Related Links

Anpac Bio-Medical Presenting ‘Breakthrough’ Cancer Screening Tech/Research At Breast Cancer Symposium

SACRAMENTO, Calif., Sept. 16, 2015 — Anpac Bio-Medical Science Company Chief Executive Officer Dr. Chris Yu and Anpac scientists will be presenting “breakthrough,” Breast Cancer screening and early detection research results at the upcoming “Breast Cancer Symposium” in San Francisco, California, September 25-27, 2015.

Reporting outcomes generated through Anpac’s novel, non-invasive, “Cancer Differentiation Analysis” (CDA) technology, Anpac’s team will share with Symposium attendees Anpac’s consistent Breast Cancer detection sensitivity and specificity rates of over 80% to date (versus standard/traditional early detection tests, generating an approximately 30% sensitivity/specificity rate).

Published earlier this year as “game changing”, by the Nobel Prize Laureate Summit on Biomedical Science (NPLS), research indicates Anpac’s CDA medical devices effectively reinvent early Breast Cancer screening and detection. By analyzing simple, in vitro, whole, “Blood Biopsies”, and applying Anpac’s proprietary, multi-level, multi-parameter, diagnostic algorithms, Anpac’s CDA technology identifies Breast Cancer with measurably-greater sensitivity, specificity, and accuracy, than most current, conventional Breast Cancer early screening methods. And it does so without any harmful side effects in patients; generating far fewer “false positives”; and at a cost substantially lower than traditional testing (such as imaging).

Of most importance to Symposium participants, Anpac’s CDA technology can reveal threatening Breast Cancer cells, before they form into tumors – key to patient survival rates. According to Cancer Research U.K., more than 90% of women diagnosed with breast cancer at the earliest stage survive their disease for at least five years; compared to around 15% for women diagnosed with the most advanced stage of disease (http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/survival#heading-Three).

The scientific Abstract outlining Anpac’s CDA Breast Cancer research samples/method, results, etc., will post September 25.

“We are excited to share our CDA findings at the Breast Cancer Symposium,” states Dr. Yu. “Our study results are very encouraging. And we hope by sharing them that we can form alliances with other Breast Cancer advocacy organizations, to expedite and launch CDA Breast Cancer clinical trials early next year. Working quickly and in partnership, we can save millions of lives through Anpac CDA screening.”

The Breast Cancer Symposium, co-sponsored by the American Societies of Breast Cancer Surgeons, Clinical Oncology, Radiation Oncology, and Surgical Oncology, is an educational, collaborative forum highlighting clinically relevant, translational science, affecting current breast cancer management.

Related Links

©2021 Anpac Bio-Medical Science Co., Ltd.